Article
The Role of Oncogenes and Redox Signaling in the Regulation of PD-L1 in Cancer
2 Sept 2021
Abstract excerpt
Tumor cells can evade the immune system via multiple mechanisms, including the dysregulation of the immune checkpoint signaling. These signaling molecules are important factors that can either stimulate or inhibit tumor immune response. Under normal physiological conditions, the interaction between programmed cell death ligand 1 (PD-L1) and its receptor, programmed cell death 1 (PD-1), negatively regulates T cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
